KU Leuven Research & Development

KU Leuven Research & Development

KU Leuven Research & Development

Overview
Headquarters

Oude Markt 13,Leuven 3000

Type of Company

Private

Executives & Employees

General Manager

Financial Controller

Managing Director

Professor

Professor

Innovation Manager

Vice-Rector Science, Engineering & Technology

Board of Directors

Chairman at Smile Invest Management Co. NV

Director at ICOS Vision Systems Corp. NV

Managing Director at Lamifil NV

Paths to KU Leuven Research & Development
Potential Connections via
Relationship Science
You
KU Leuven Research & Development
Clients

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by KU Leuven Research & Development. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of KU Leuven Research & Development's profile does not indicate a business or promotional relationship of any kind between RelSci and KU Leuven Research & Development.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/ku-leuven-research-and-development-1569185
  • https://relationshipscience.com/organization/ku-leuven-research-and-development-1569185